We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBIS
751
Nebius Group N.V.
NBIS
$47.7B
| $778K | 0.01% |
+36,948
| New | +$804K |
|
752
Brunswick
BC
$5.19B
| $777K | 0.01% |
15,931
-158,989
| -91% | -$7.59M |
|
753
Rigel Pharmaceuticals
RIGL
$680M
| $765K | 0.01% |
+20,851
| New | +$598K |
|
|
AZPN
754
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $757K | 0.01% |
+16,182
| New | +$757K |
|
|
JOYY
755
JOYY Inc
JOYY
$3.73B
| $740K | 0.01% |
13,892
-82,557
| -86% | -$3.77M |
|
|
LHCG
756
DELISTED
LHC Group LLC
LHCG
| $731K | 0.01% |
19,812
-8,584
| -30% | -$344K |
|
|
TRHC
757
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $716K | 0.01% |
+50,000
| New | +$730K |
|
758
Mitsubishi UFJ Financial
MUFG
$258B
| $710K | 0.01% |
140,496
+36,405
| +35% | +$184K |
|
|
CALY
759
Callaway Golf Company
CALY
$3.26B
| $707K | 0.01% |
60,862
-368,884
| -86% | -$4.11M |
|
760
TETRA Technologies
TTI
$1.23B
| $703K | 0.01% |
115,087
-454,139
| -80% | -$2.76M |
|
|
INFN
761
DELISTED
Infinera Corporation Common Stock
INFN
| $702K | 0.01% |
77,761
-151,086
| -66% | -$1.46M |
|
762
St. Joe Company
JOE
$3.57B
| $695K | ﹤0.01% |
+37,789
| New | +$703K |
|
763
RingCentral
RNG
$4.05B
| $678K | ﹤0.01% |
28,644
-115,520
| -80% | -$2.61M |
|
|
CUDA
764
DELISTED
Barracuda Networks, Inc.
CUDA
| $676K | ﹤0.01% |
+26,537
| New | +$583K |
|
765
Salesforce
CRM
$134B
| $663K | ﹤0.01% |
9,299
-84,039
| -90% | -$6.55M |
|
|
RTN
766
DELISTED
Raytheon Company
RTN
| $661K | ﹤0.01% |
+4,853
| New | +$675K |
|
767
Genuine Parts
GPC
$17.1B
| $655K | ﹤0.01% |
+6,518
| New | +$661K |
|
768
Photronics
PLAB
$1.79B
| $650K | ﹤0.01% |
62,998
-181,822
| -74% | -$1.75M |
|
769
HEICO Corp
HEI
$48.9B
| $649K | ﹤0.01% |
+22,908
| New | +$647K |
|
|
CHK
770
DELISTED
Chesapeake Energy Corporation
CHK
| $649K | ﹤0.01% |
+517
| New | +$596K |
|
|
BGC
771
DELISTED
General Cable Corporation
BGC
| $644K | ﹤0.01% |
+42,959
| New | +$631K |
|
772
Leggett & Platt
LEG
$1.52B
| $639K | ﹤0.01% |
14,027
-138,032
| -91% | -$7.09M |
|
773
Fair Isaac
FICO
$28.7B
| $636K | ﹤0.01% |
+5,104
| New | +$637K |
|
|
BWP
774
DELISTED
Boardwalk Pipeline Partners
BWP
| $626K | ﹤0.01% |
+36,496
| New | +$616K |
|
775
Jabil
JBL
$32.8B
| $619K | ﹤0.01% |
+28,389
| New | +$591K |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.